First National Bank of Omaha’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
Sell
-8,520
Closed -$218K 411
2013
Q4
$218K Sell
8,520
-5,225
-38% -$161K 0.02% 366
2013
Q3
$411K Buy
13,745
+3,805
+38% +$106K 0.04% 314
2013
Q2
$285 Buy
+9,940
New +$274K 0.02% 344

Other funds holding BRLI

First National Bank of Omaha's BRLI Position: Q1 2014 in Review

First National Bank of Omaha sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q1 2014, closing a stake of 8,520 shares — an estimated $218K sold.

First National Bank of Omaha first reported a position in BRLI in Q2 2013 and held it in 3 quarters. The position peaked at $411K in Q3 2013. 162 funds tracked by Wall St. Rank hold BRLI as of Q1 2014.

  • First National Bank of Omaha reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q1 2014 after selling out during the quarter.
  • First National Bank of Omaha sold 8,520 BIO-REFERENCE LABS INC-NEW- shares in Q1 2014, an estimated $218K.
  • First National Bank of Omaha first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 3 quarters.
  • First National Bank of Omaha's BIO-REFERENCE LABS INC-NEW- position peaked at $411K in Q3 2013.
  • 162 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q1 2014.

Based on First National Bank of Omaha's 13F filing for Q1 2014, filed 14 May 2014.